[go: up one dir, main page]

FR2846008B1 - Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees - Google Patents

Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees

Info

Publication number
FR2846008B1
FR2846008B1 FR0213022A FR0213022A FR2846008B1 FR 2846008 B1 FR2846008 B1 FR 2846008B1 FR 0213022 A FR0213022 A FR 0213022A FR 0213022 A FR0213022 A FR 0213022A FR 2846008 B1 FR2846008 B1 FR 2846008B1
Authority
FR
France
Prior art keywords
molecules
crible
kits
screening
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0213022A
Other languages
English (en)
Other versions
FR2846008A1 (fr
Inventor
Marc Blondel
Stephane Bach
Christophe Cullin
Nicolas Talarek
Jean Michel Vierfond
Yvette Renoult Mettey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Universite de Poitiers
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Universite de Poitiers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2, Universite de Poitiers filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0213022A priority Critical patent/FR2846008B1/fr
Priority to FR0308289A priority patent/FR2846009B1/fr
Priority to AT03778411T priority patent/ATE349550T1/de
Priority to PCT/FR2003/003101 priority patent/WO2004035813A2/fr
Priority to JP2005501302A priority patent/JP4529030B2/ja
Priority to ES03778411T priority patent/ES2279975T3/es
Priority to US10/531,594 priority patent/US8129402B2/en
Priority to DE60310744T priority patent/DE60310744T2/de
Priority to EP03778411A priority patent/EP1551992B1/fr
Priority to CA2502544A priority patent/CA2502544C/fr
Priority to AU2003285413A priority patent/AU2003285413A1/en
Publication of FR2846008A1 publication Critical patent/FR2846008A1/fr
Application granted granted Critical
Publication of FR2846008B1 publication Critical patent/FR2846008B1/fr
Priority to US11/483,822 priority patent/US20070031821A1/en
Priority to US12/858,235 priority patent/US20110092483A1/en
Priority to US13/328,611 priority patent/US20120122916A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0213022A 2002-10-18 2002-10-18 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees Expired - Fee Related FR2846008B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0213022A FR2846008B1 (fr) 2002-10-18 2002-10-18 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
FR0308289A FR2846009B1 (fr) 2002-10-18 2003-07-07 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
CA2502544A CA2502544C (fr) 2002-10-18 2003-10-20 Criblage de molecules a activite anti-prion: kits, methodes et molecules criblees
JP2005501302A JP4529030B2 (ja) 2002-10-18 2003-10-20 抗プリオン活性を有する分子のスクリーニングキットおよび抗プリオン活性を有する分子のスクリーニング方法およびスクリーニングされた分子
ES03778411T ES2279975T3 (es) 2002-10-18 2003-10-20 Cribado de moleculas con actividad antiprionica: kits, metodos y moleculas cribadas.
US10/531,594 US8129402B2 (en) 2002-10-18 2003-10-20 Screening molecules with anti-prion activity: kits, methods and screened molecules
DE60310744T DE60310744T2 (de) 2002-10-18 2003-10-20 Reihentestverfahren auf moleküle mit anti-prionaktivität: kits, methoden und moleküle
EP03778411A EP1551992B1 (fr) 2002-10-18 2003-10-20 Criblage de molecules a activite anti-prion : kits, methodes et molecules criblees
AT03778411T ATE349550T1 (de) 2002-10-18 2003-10-20 Reihentestverfahren auf moleküle mit anti- prionaktivität: kits, methoden und moleküle
AU2003285413A AU2003285413A1 (en) 2002-10-18 2003-10-20 Screening molecules with anti-prion activity: kits, methods and screened molecules
PCT/FR2003/003101 WO2004035813A2 (fr) 2002-10-18 2003-10-20 Criblage de molecules a activite anti-prion : kits, methodes et molecules criblees
US11/483,822 US20070031821A1 (en) 2002-10-18 2006-07-11 Screening molecules with anti-prion activity: kits, methods and screened molecules
US12/858,235 US20110092483A1 (en) 2002-10-18 2010-08-17 Screening molecules with anti-prion activity: kits, methods and screened molecules
US13/328,611 US20120122916A1 (en) 2002-10-18 2011-12-16 Screening molecules with anti-prion activity: kits, methods and screened molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213022A FR2846008B1 (fr) 2002-10-18 2002-10-18 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees

Publications (2)

Publication Number Publication Date
FR2846008A1 FR2846008A1 (fr) 2004-04-23
FR2846008B1 true FR2846008B1 (fr) 2006-06-02

Family

ID=32050534

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0213022A Expired - Fee Related FR2846008B1 (fr) 2002-10-18 2002-10-18 Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees

Country Status (1)

Country Link
FR (1) FR2846008B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007056580A2 (fr) * 2005-11-08 2007-05-18 Pharmadyn, Inc. Procedes et compositions pour traiter des maladies associees a des proteines pathogenes
EP1847604A1 (fr) * 2006-04-19 2007-10-24 Millegen Procédé intracellulaire de sélection d'un peptide ou d'un polypeptide entrant en intéraction avec un peptide appât ou un polypeptide appât

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
DE2430380C3 (de) * 1974-06-25 1980-04-30 Behringwerke Ag, 3550 Marburg Herstellung eines Stoffes mit immunologischer Wirkung
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US7799535B1 (en) * 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
EP1392849B2 (fr) * 2001-02-15 2012-01-18 University Of Chicago Cribles a base de levure pour le traitement de maladies humaines

Also Published As

Publication number Publication date
FR2846008A1 (fr) 2004-04-23

Similar Documents

Publication Publication Date Title
NO2017061I1 (no) inotuzumab ozogamicin
FI20011877L (fi) Menetelmä ja bioanturi analyysiä varten
FI20041323A0 (fi) Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi
EP1482307A4 (fr) Biodetecteur
ATE412220T1 (de) Fft-architektur und -verfahren
FR2843963B1 (fr) Nouvelles molecules derivees de la noraporphine
DE60328069D1 (de) Test-Photomaske, Streulichtbewertungsverfahren, und Streulichtkompensierungsverfahren
DE60330400D1 (de) Sprachsynthesesystem, Sprachsyntheseverfahren und Rechnerprogramm
EP2037272A4 (fr) Trousse de detection et de quantification d'analyte, et procede de detection et de quantification d'analyte
EP1539931A4 (fr) Agents de modulation de la differenciation et utilisations associees
FI20030893L (fi) Näppäimistö ja menetelmä sen valmistamiseksi
FI20030463A0 (fi) Monikanavainen testiväline, menetelmä sen valmistamiseksi ja sen käyttö
EP1699485A4 (fr) Anticorps anti-hydroxylase et utilisations
NO20040295L (no) Fremgansmate for testing av samhandlingen mellom en vaeskeprove og en respektiv fast prove
EP1824467A4 (fr) Apogossypolone et utilisations associees
EP1962093A4 (fr) Analyseur et procede d'analyse
DE60224263D1 (de) Bestimmung der statistischen Analyse von Signalen
FR2846008B1 (fr) Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees
ITMI20022384A1 (it) Sanitari da bagno in legno e procedimento per la loro produzione.
DE60317022D1 (de) Biosensor
EP1539957A4 (fr) Nouvelles methodes de diagnostic et de therapie et reactifs correspondants
FI20030718A0 (fi) Laitteisto ja menetelmä kone-elimen tilan tarkkailemiseksi
FI20040831L (fi) Rannetietokone ja menetelmä sen yhteydessä
FR2839079B1 (fr) Banque genomique du cyanophage s-2l et analyse fonctionnelle partielle
EP1615552A4 (fr) Saphirines et utilisations correspondantes

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160630